Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Knight Therapeutics Inc
T.GUD
Alternate Symbol(s):
KHTRF
Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select...
international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:GUD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(152)
•••
longrun86
X
View Profile
View Bullboard History
Comment by
longrun86
on Aug 08, 2022 10:00am
RE:RE:RE:Expectations
I am focussed mostly on the operating performance this Quarter. My wish list would be revenue north of $68 million and operating EBITDA greater than $15 million. Adding to my wish list, I would
...more
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Comment by
gudisgood
on Aug 07, 2022 4:16pm
RE:RE:Expectations
NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets
posted Nov 14, 2024 9:00am by
NurExone Biologic Inc.
-
|
“We are honored by the EMA’s recognition of ExoPTEN through the Orphan Medicinal Product Designation, which significantly advances our ability to enter the European market and offers hope to those impacted by acute spinal cord injuries,” said Dr. Lior Shaltiel, Chief Executive Officer of NurExone. “This designation, together with the ...read more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Aug 07, 2022 11:56am
RE:Expectations
Haven't been paying attention to this lately but - investment in Singlar G also took another hit as the stock likely bottomed in the last quarter and we will probably take an adjustment hit.
...more
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Post by
gudisgood
on Aug 04, 2022 8:27am
Expectations
Some random thoughts now that we're a week away from the report: We should be getting closer to a more normal course of doing business – as “normal” as we can be at this point, anyway. Perhaps a
...more
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Comment by
gudisgood
on Aug 04, 2022 7:31am
RE:Interesting at least
Thanks for posting this. I doubt this reflects any meaningful changes in GUD's potential. I doubt much changed within the past month. The only clear change, in fact, was the stock price, which
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 04, 2022 7:30am
New Press Release - Notice of Knight Therapeutics' Second Quarter 2022 Results Conference Call
MONTREAL, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, will release its second quarter 2022 financial results on Thursday, August 11, 2022 prior to market opening. Following the release, Knight...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 04, 2022 7:30am
New Press Release - Knight to Present at the Canaccord Genuity 42nd Annual Growth Conference
MONTREAL, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading pan-American (ex-US) specialty pharmaceutical company, announced today that Amal Khouri, Chief Business Officer, is scheduled to present at Canaccord Genuity 42nd Annual Growth Conference on...
read article.
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Aug 03, 2022 8:19pm
RE:RE:RE:RE:Interesting at least
THe pooch goes back where it belongs ....the dog house
(8)
•••
wofats
X
View Profile
View Bullboard History
Comment by
wofats
on Aug 03, 2022 7:36pm
RE:RE:RE:Interesting at least
They did it again ,smaller this time $-201,338.55 -34,500 vol $5.84 each
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Aug 03, 2022 3:13pm
Moderna jumping on earnings
and they only have one commerciaily available product, to fight COVID, as read on CNBC. GUD has a number of different product streams up and running and building and will grow over time simply based
...more
(152)
•••
longrun86
X
View Profile
View Bullboard History
Comment by
longrun86
on Aug 02, 2022 11:29pm
RE:RE:RE:Interesting at least
Never under-estimate the role tax planning has and other things that are unique to each investor are. Until you see a material transaction, everything else is just noise.
(14)
•••
Candyswanwick
X
View Profile
View Bullboard History
Comment by
Candyswanwick
on Aug 02, 2022 6:58pm
RE:RE:Interesting at least
Isn't this the same guy that is notorious for hostile take overs?
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Aug 02, 2022 6:48pm
RE:Interesting at least
He got the reality drift of GUD and running for the woods while he can. No surprices typicl of GUD's bag holder fortunes. Sell ..........
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Aug 02, 2022 2:47pm
RE:RE:Interesting at least
Think it's more interesting to see how the market runs for cover - scared silly by it. Would be interesting to see if they made a few smaller winning sells in order to move cash to some depressed
...more
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
New Gold and Copper Hotspot Identified – What’s Next for This Serbian Project?
Major Funding Secured! Company Closes First Round of Private Placement
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023
Gold, growth and sustainability in focus for this resource company
Star Diamond Corporation Announces Third Quarter 2024 Results
This $10M Deal Could Reshape the Future of Global Creator Platforms
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
Explained: The Psychology of Options Trading with Practical Tips
Meet the Top 5 Best Online Brokerages in Canada